Hims & Hers Reports Q1 Earnings Miss but Maintains Long-Term Growth Outlook

Hims & Hers Health (NYSE: HIMS) reported a significant earnings miss in Q1 FY2026, with an EPS of -$0.44 versus expectations of $0.04 and revenue below estimates at $608 million. Despite the stock dropping nearly 23%, management remains optimistic due to long-term growth forecasts across core segments and strategic partnerships.

By Jessica Mitacek, MarketBeat Thu, May 21, 2026 at 6:40 PM GMT+3 5 min read · Yahoo Finance · May 21, 2026, 15:40 UTC

Tickers: $HIMS $NVO

Topics: acquisition GLP-1 partnership telehealth weight loss market

Read the full article at Yahoo Finance

More World news

Nvidia Names Colette Kress Interim CEO Following Jensen Huang's Resignation Motley Fool · November 12, 2026, 18:26 UTC
Bit Digital Reports Q3 2026 Net Income of $28.5 Million Amid Revenue Decline Motley Fool · November 12, 2026, 18:26 UTC
EZCORP Reports Strong Q4 2026 Results with Significant EBITDA and Revenue Growth Motley Fool · November 12, 2026, 18:16 UTC
Sabre Corp Shares Decline Following Travelport Denial of Merger Speculation Seeking Alpha · November 12, 2026, 18:21 UTC
Lufax Reports Third Quarter 2026 Net Loss Amid Rising Credit Impairment Costs Motley Fool · November 12, 2026, 18:15 UTC
Avantor Reports Return to Organic Revenue Growth in Third Quarter 2026 Motley Fool · November 12, 2026, 18:15 UTC
MGP Ingredients Rebrands to Sempreon and Announces Strategic Shift Toward Ready-to-Drink Products Motley Fool · November 12, 2026, 18:15 UTC
ICON Reports Q3 2026 Revenue of $2 Billion and Accelerating Book-to-Bill Ratio Motley Fool · November 12, 2026, 18:15 UTC
Beachbody (BODi) Reduces Annual Revenue Breakeven to $125 Million Amid Strategic Pivot Motley Fool · November 12, 2026, 18:15 UTC
Standard Nuclear Reports $577.2 Million Contract Backlog and Targets 2027 DOE Authorization Seeking Alpha · November 12, 2026, 18:10 UTC